[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2018011593A - Uso de probioticos en el tratamiento y/o la prevencion de la enfermedad de la psoriasis. - Google Patents

Uso de probioticos en el tratamiento y/o la prevencion de la enfermedad de la psoriasis.

Info

Publication number
MX2018011593A
MX2018011593A MX2018011593A MX2018011593A MX2018011593A MX 2018011593 A MX2018011593 A MX 2018011593A MX 2018011593 A MX2018011593 A MX 2018011593A MX 2018011593 A MX2018011593 A MX 2018011593A MX 2018011593 A MX2018011593 A MX 2018011593A
Authority
MX
Mexico
Prior art keywords
psoriasis
prevention
treatment
probiotics
lactis
Prior art date
Application number
MX2018011593A
Other languages
English (en)
Inventor
Ramón Vidal Daniel
Genovés Martínez Salvador
Manuel Navarro López Vicente
Adela Ramírez Boscá Ana
Manuel Pérez Orquín José
Empar Chenoll Cuadros María
Manuel Codoñer Cortés Francisco
Original Assignee
Bionou Research Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionou Research Sl filed Critical Bionou Research Sl
Publication of MX2018011593A publication Critical patent/MX2018011593A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención va dirigida al uso de una composición probiótica que comprende Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium Iongum y Lactobacillus rhamnosus, en particular, las cepas B. lactis CECT 8145, B. Iongum ES1 CECT 7347 y/o L. rhamnosus CECT 8361, en el tratamiento y/o prevención de los brotes de psoriasis o la psoriasis.
MX2018011593A 2016-03-21 2017-03-21 Uso de probioticos en el tratamiento y/o la prevencion de la enfermedad de la psoriasis. MX2018011593A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382122.6A EP3222282A1 (en) 2016-03-21 2016-03-21 Use of probiotics in the treatment and/or prevention of psoriasis
PCT/EP2017/056719 WO2017162683A1 (en) 2016-03-21 2017-03-21 Use of probiotics in the treatment and/or prevention of psoriasis

Publications (1)

Publication Number Publication Date
MX2018011593A true MX2018011593A (es) 2020-01-30

Family

ID=55969084

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011593A MX2018011593A (es) 2016-03-21 2017-03-21 Uso de probioticos en el tratamiento y/o la prevencion de la enfermedad de la psoriasis.

Country Status (25)

Country Link
US (1) US10912802B2 (es)
EP (2) EP3222282A1 (es)
KR (1) KR102303587B1 (es)
CN (1) CN110325198B (es)
AR (1) AR107921A1 (es)
AU (1) AU2017238300B2 (es)
CA (1) CA3018625A1 (es)
DK (1) DK3432899T3 (es)
EA (1) EA201891908A1 (es)
ES (1) ES2873889T3 (es)
HR (1) HRP20211173T1 (es)
HU (1) HUE055635T2 (es)
IL (1) IL261932B2 (es)
MA (1) MA43488B1 (es)
MX (1) MX2018011593A (es)
MY (1) MY193275A (es)
PE (1) PE20190432A1 (es)
PH (1) PH12018502042A1 (es)
PL (1) PL3432899T3 (es)
PT (1) PT3432899T (es)
RS (1) RS62101B1 (es)
RU (1) RU2767967C2 (es)
SI (1) SI3432899T1 (es)
UA (1) UA127180C2 (es)
WO (1) WO2017162683A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800002052A1 (it) 2018-01-26 2019-07-26 Girolamo Stefano Di Probiotico per il trattamento della psoriasi
EP3851115A1 (en) * 2020-01-15 2021-07-21 Biopolis, S.L. Probiotic composition for its use as an antioxidant
US20210275612A1 (en) * 2020-03-09 2021-09-09 Glac Biotech Co., Ltd. Method for alleviating inflammation-related disorder
CN113142554A (zh) * 2020-06-09 2021-07-23 江苏佰澳达生物科技有限公司 一种改善头皮屑产生的益生菌发酵液及其应用
EP3967318A1 (en) * 2020-09-14 2022-03-16 Bionou Research, S.L. Probiotic compositions for the treatment of acne
CN112159778B (zh) * 2020-09-30 2021-12-03 江南大学 一株可缓解银屑病的动物双歧杆菌及其应用
WO2022090474A1 (en) * 2020-10-29 2022-05-05 Deerland Probiotics & Enzymes A/S Microencapsulated microbial composition
CN112546074B (zh) * 2020-12-24 2022-09-27 江南大学 一株能够抑制IL-23、Th17轴相关炎症因子释放的短双歧杆菌及其应用
CN112812989B (zh) * 2020-12-31 2022-06-10 江南大学 一种能够缓解银屑病的青春双歧杆菌及其应用
CN113088473B (zh) * 2021-04-27 2022-08-02 江南大学 一株具有缓解HaCaT细胞氧化损伤作用的动物双歧杆菌
CN113455549B (zh) * 2021-06-29 2022-09-13 黑龙江飞鹤乳业有限公司 一种奶酪产品及其制备方法和应用
CA3239145A1 (en) * 2021-12-16 2023-06-22 Maria Empar Chenoll Cuadros Use of postbiotics in the treatment and/or prevention of anxiety disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04008182A (es) * 2002-02-21 2005-06-08 Oreal Composicion fotoprotectora para la piel, oralmente adminstrable.
JP2004250337A (ja) 2003-02-18 2004-09-09 Sunstar Inc アレルギー疾患改善用製剤
CN101325960B (zh) * 2005-10-06 2012-05-30 普罗比公司 乳酸杆菌用于治疗自身免疫性疾病的用途
ES2590916T3 (es) * 2005-10-06 2016-11-24 Probi Ab Uso de Lactobacillus para el tratamiento de infecciones por virus
ES2343499B1 (es) * 2007-12-24 2011-06-10 Consejo Superior De Investigaciones Cientificas Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
EP2704704B1 (en) * 2011-05-03 2018-09-26 DuPont Nutrition Biosciences ApS Probiotic bacteria for the topical treatment of skin disorders
KR20130049554A (ko) 2011-11-04 2013-05-14 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물
KR101453982B1 (ko) * 2012-09-19 2014-10-28 주식회사 쎌바이오텍 과민성 대장 증후군 예방 또는 치료용 조성물
ES2526986B1 (es) * 2013-07-18 2015-11-02 Biopolis, S.L. Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
KR101724601B1 (ko) 2014-11-04 2017-04-10 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
TWI790189B (zh) * 2015-01-02 2023-01-21 美商梅拉洛伊卡公司 細菌組成物

Also Published As

Publication number Publication date
AU2017238300B2 (en) 2024-07-11
ES2873889T3 (es) 2021-11-04
PL3432899T3 (pl) 2021-11-22
CN110325198B (zh) 2024-04-30
EP3432899A1 (en) 2019-01-30
IL261932A (en) 2018-10-31
EA201891908A1 (ru) 2019-04-30
PT3432899T (pt) 2021-07-05
EP3432899B1 (en) 2021-04-28
US20190328799A1 (en) 2019-10-31
BR112018069284A2 (pt) 2019-03-06
WO2017162683A1 (en) 2017-09-28
KR20190008849A (ko) 2019-01-25
KR102303587B1 (ko) 2021-09-17
RU2018136939A3 (es) 2020-05-13
AU2017238300A1 (en) 2018-11-01
RU2018136939A (ru) 2020-04-22
UA127180C2 (uk) 2023-05-31
RS62101B1 (sr) 2021-08-31
CA3018625A1 (en) 2017-09-28
MY193275A (en) 2022-09-29
CN110325198A (zh) 2019-10-11
PE20190432A1 (es) 2019-03-21
EP3222282A1 (en) 2017-09-27
SI3432899T1 (sl) 2021-12-31
MA43488B1 (fr) 2020-10-28
IL261932B2 (en) 2023-04-01
PH12018502042A1 (en) 2019-07-15
DK3432899T3 (da) 2021-07-05
HUE055635T2 (hu) 2021-12-28
AR107921A1 (es) 2018-06-28
HRP20211173T1 (hr) 2021-10-15
US10912802B2 (en) 2021-02-09
IL261932B (en) 2022-12-01
MA43488A1 (fr) 2019-12-31
RU2767967C2 (ru) 2022-03-23

Similar Documents

Publication Publication Date Title
PH12018502042A1 (en) Use of probiotics in the treatment and/or prevention of psoriasis
PH12019500123A1 (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
MX2011012069A (es) Micro-organismos no-replicantes y su efecto inmuno estimulador.
PH12018502406A1 (en) Nutritional composition comprising a probiotic for the prevention and/or treatment of anxiety disorders and related conditions in a mammal
EP4012019C0 (en) BIFIDOBACTERIUM BREVE 207-1 AND ITS USE
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
ZA202105310B (en) Probiotic compositions comprising lactobacillus reuteri strains and methods of use
DK3554517T3 (da) Probiotisk sammensætning omfattende lactobacillus rhamnosus og lactobacillus paracasei stammer
MX2017007654A (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas.
HRP20130487A2 (hr) Formulacija probiotika s apigeninom i ekstraktom paprene metvice
HK1198326A1 (zh) 用於預防或治療上呼吸道感染的鼠李糖乳桿菌和動物雙歧桿菌乳亞種
PH12017502042A1 (en) Dietary supplement
MX2017008700A (es) Empleo de probioticos en el incremento de la fertilidad masculina.
EP3601525C0 (en) PROBIOTIC LACTOBACILLUS CASEI STRAIN AND ITS USES
MX2024006254A (es) Uso de postbioticos en el tratamiento y/o prevencion de los trastornos de ansiedad.
MX2020007906A (es) Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas.
UA120331U (uk) Пробіотик "болмол"
UA89037U (uk) Кормова добавка з пробіотичною дією "пробіолакт"
RS54225B1 (en) Indigenous LACTOBACILLUS strains and their use as probiotics
PL406051A1 (pl) Zastosowanie kompozycji probiotycznej
LT2013502A (lt) Maistinio arba farmacinio biopreparato kompozicija